New Study From IHU Méditerranée Infection, Marseille, France Shows Antibody-Dependent Enhancement Occurs in Humans in Weeks 1 and 2 Following COVID-19 Vaccine Administration
My 2020 analysis of efficacy after the first trials said 75%, not 95%. Animal studies against Wuhan mRNA spike vaccines were not enough and ADE should have been studied again with new variants.